BioWorld

May 10, 2002

Bush's Zerhouni Confirmed By Senate As NIH Director

WASHINGTON - President Bush's choice as director of the National Institutes of Health won Senate confirmation, just in time to enter the pending debate on Capitol Hill concerning therapeutic cloning. (BioWorld Today) Read More

Onyx Placement Gets $20M To Pursue Anticancer Drugs

Merck Scientists' Compound Pinpoints B. anthracis Lethal Toxin As Antibiotics Adjunct

Genome Canada Supporting National Genomics Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Feb. 3, 2025.

Today's news in brief

Briefs

BioWorld MedTech briefs for Jan. 30, 2026.

Illustration of brain with neuron receptor

5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

BioWorld Science

Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...

MicroRNAs in circulating extracellular vesicles as IPF biomarkers

BioWorld Science

MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...